Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.
Mon, 28 Mar 2016 13:16:00 +00004 Surging Stocks Brokers Love in the Healthcare Sector
Mon, 15 Sep 2014 05:33:48 +0000Monday Sector Laggards: Biotechnology, Application Software Stocks
Tue, 24 Dec 2013 14:18:10 +0000Synthetic Biologics (SYN) in Focus: Stock Surges 18.1% - Tale of the Tape
Foxchart international: United States Canada United Kingdom Australia New Zealand Singapore India
©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX